Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

BACKGROUND: HIV-infected men are at increased risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer caused by vaccine types. METHODS: AIDS Malignancy Consortium Protocol 052 is a single-arm, open-label, multi-center clinical trial to assess the safety and immunogenicit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wilkin, Timothy, Lee, Jeannette Y., Lensing, Shelly Y., Stier, Elizabeth A., Goldstone, Stephen E., Berry, J. Michael, Jay, Naomi, Aboulafia, David, Cohn, David L., Einstein, Mark H., Saah, Alfred, Mitsuyasu, Ronald T., Palefsky, Joel M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3118428/
https://ncbi.nlm.nih.gov/pubmed/20812850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/656320
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky